Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy.

Saved in:
Bibliographic Details
Title: Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy.
Authors: Belge Bilgin G; Department of Radiology, Mayo Clinic, Rochester, MN, United States., Bilgin C; Department of Radiology, Mayo Clinic, Rochester, MN, United States., Childs DS; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States., Orme JJ; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States., Burkett BJ; Department of Radiology, Mayo Clinic, Rochester, MN, United States., Packard AT; Department of Radiology, Mayo Clinic, Rochester, MN, United States., Johnson DR; Department of Radiology, Mayo Clinic, Rochester, MN, United States., Thorpe MP; Department of Radiology, Mayo Clinic, Rochester, MN, United States., Riaz IB; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, United States., Halfdanarson TR; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States., Johnson GB; Department of Radiology, Mayo Clinic, Rochester, MN, United States.; Department of Immunology, Mayo Clinic, Rochester, MN, United States., Sartor O; Department of Radiology, Mayo Clinic, Rochester, MN, United States.; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.; Department of Urology, Mayo Clinic, Rochester, MN, United States., Kendi AT; Department of Radiology, Mayo Clinic, Rochester, MN, United States.
Source: Frontiers in oncology [Front Oncol] 2024 Jul 12; Vol. 14, pp. 1386718. Date of Electronic Publication: 2024 Jul 12 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39070149
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer <superscript>177</superscript>Lu-PSMA-617 therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Belge+Bilgin+G%22">Belge Bilgin G</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Bilgin+C%22">Bilgin C</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Childs+DS%22">Childs DS</searchLink>; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Orme+JJ%22">Orme JJ</searchLink>; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Burkett+BJ%22">Burkett BJ</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Packard+AT%22">Packard AT</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Johnson+DR%22">Johnson DR</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Thorpe+MP%22">Thorpe MP</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Riaz+IB%22">Riaz IB</searchLink>; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Halfdanarson+TR%22">Halfdanarson TR</searchLink>; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Johnson+GB%22">Johnson GB</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.; Department of Immunology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Sartor+O%22">Sartor O</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.; Department of Urology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Kendi+AT%22">Kendi AT</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Jul 12; Vol. 14, pp. 1386718. <i>Date of Electronic Publication: </i>2024 Jul 12 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39070149
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2024.1386718
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1386718
    Titles:
      – TitleFull: Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Belge Bilgin G
      – PersonEntity:
          Name:
            NameFull: Bilgin C
      – PersonEntity:
          Name:
            NameFull: Childs DS
      – PersonEntity:
          Name:
            NameFull: Orme JJ
      – PersonEntity:
          Name:
            NameFull: Burkett BJ
      – PersonEntity:
          Name:
            NameFull: Packard AT
      – PersonEntity:
          Name:
            NameFull: Johnson DR
      – PersonEntity:
          Name:
            NameFull: Thorpe MP
      – PersonEntity:
          Name:
            NameFull: Riaz IB
      – PersonEntity:
          Name:
            NameFull: Halfdanarson TR
      – PersonEntity:
          Name:
            NameFull: Johnson GB
      – PersonEntity:
          Name:
            NameFull: Sartor O
      – PersonEntity:
          Name:
            NameFull: Kendi AT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 07
              Text: 2024 Jul 12
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1